[
    {
        "utterance": "Shwetadwip Chowdhury: anyone you can either log in and write it yourself or you can tell me what to write in. I took a few notes while we were talking, but I don't think that I have nearly a comprehensive list. ",
        "annotations": {
            "process management": "The speaker is instructing on how to proceed with the task, which involves managing the meeting flow and organizing group activities.",
            "assign task": "The speaker is assigning responsibility to group members by giving them options on how to contribute to the task."
        }
    },
    {
        "utterance": "Brian Pogue: Is there sort of a higher or super structure to what we discussed? ",
        "annotations": {
            "ask question": "The speaker is requesting information about the structure of what has been discussed, making this an explicit question."
        }
    },
    {
        "utterance": "Ping Wang: Excuse me, can you add my name? I mean, I'm sorry. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brian Pogue: Yeah, I think. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ping Wang: I don't have access to the slide. I don't know. I couldn't find it from the Google Doc. ",
        "annotations": {
            "identify gap": "Ping Wang is explicitly recognizing their lack of access to a resource (the slide) and inability to find something in the Google Doc."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Uh, why don't I just put this in the chat and maybe you can um. ",
        "annotations": {
            "process management": "The speaker is suggesting a way to manage the flow of information by proposing to put something in the chat."
        }
    },
    {
        "utterance": "Ping Wang: Okay. Oh, somebody already did it. Somebody already did it. There you go. ",
        "annotations": {
            "acknowledge contribution": "verbally recognizes another group member's input, as Ping Wang acknowledges that someone added her name to the document."
        }
    },
    {
        "utterance": "Brad Smith: Well, I think the first point here might be that this problem gets a lot harder as you get further up the chain, you know, so so obviously it on mono layers or cultures or even as we've learned from Crystal embryos, but then once you start getting to an immune system, you're in trouble. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a concept, providing more details, and using examples (mono layers or cultures, Crystal embryos, immune system) to clarify their point."
        }
    },
    {
        "utterance": "Brad Smith: And that's something maybe I hadn't appreciated. There's definitely threshold points where this problem gets a lot harder a lot quickly. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a thought that has been previously mentioned, providing further insight or clarification on the problem discussed.",
            "identify gap": "The speaker mentions something they 'hadn't appreciated,' indicating a recognition of their own lack of awareness or understanding about a particular aspect of the problem."
        }
    },
    {
        "utterance": "Crystal Rogers: I would say the issue here is yeah, scale, time, and then complexity. ",
        "annotations": {
            "develop idea": "Crystal Rogers is expanding on existing ideas by specifying scale, time, and complexity as key issues, thereby elaborating on the challenges of the problem."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Uh, time meaning acquisition time or what? ",
        "annotations": {
            "ask question": "The speaker is requesting clarification on the meaning of 'time' as mentioned by another group member, specifically if it refers to 'acquisition time'."
        }
    },
    {
        "utterance": "Crystal Rogers: Well, that that's relevant too, but no, I actually meant um well, yeah, I guess that's relevant acquisition time, but also the amount of time that it takes between when you give the epitope or the treatment or the marker and the time that you're then going to image it whether or not that gets diluted or lost or attacked. So there's two different time issues. ",
        "annotations": {
            "develop idea": "The speaker expands on a previous point about time issues, providing more details and clarification on the concept."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Uh, what's up? ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Uh, to dimensional imaging. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Allison Dennis: You're definitely going to have to economize on words though here. ",
        "annotations": {
            "process management": "The speaker is trying to manage the discussion flow by suggesting participants need to be concise in their communication."
        }
    },
    {
        "utterance": "Brian Pogue: Right. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Brian Pogue: Or I could. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Just decrease it. ",
        "annotations": {
            "offer feedback": "The speaker provides a suggestion for improvement or adjustment by saying 'Just decrease it.'"
        }
    },
    {
        "utterance": "Brian Pogue: There you go. ",
        "annotations": {
            "acknowledge contribution": "The utterance 'There you go.' acknowledges that an action has been taken or something has been provided, implicitly recognizing a contribution or effort made by another group member."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Um. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Arnold Hayer: With increasing with increasing complexity also the uh the ability or the opportunity to measure subcellular properties will decrease, I guess. ",
        "annotations": {
            "propose new idea": "Arnold Hayer introduces a new idea about the relationship between complexity and the ability to measure subcellular properties.",
            "develop idea": "Arnold Hayer elaborates on the concept of complexity and its impact on measurement capabilities, providing more insight into the phenomenon."
        }
    },
    {
        "utterance": "Arnold Hayer: In a simple transparent system you might be able to monitor like a few different parameters, but uh in a very complex system you might just be able to track the movement of cells and that's all. ",
        "annotations": {
            "develop idea": "The speaker expands on an existing idea by explaining how the complexity of a system affects the ability to monitor parameters, providing a specific example of the limitations in complex systems.",
            "signal expertise": "The speaker implicitly signals expertise by providing an informed explanation of the challenges in measuring parameters in complex systems."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Um, yeah, sorry, can you repeat that? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on a prior statement by asking someone to repeat what they said."
        }
    },
    {
        "utterance": "Arnold Hayer: No, I just meant uh because you said it task gets harder as you start moving to more complex cell systems, also if you you know, you might find a sweet spot where you can make really interesting discoveries by by being able and um to to track the cells and in addition to the just tracking their movement, you might be able to monitor intracellular activities at the same time or some other properties. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea that complex cell systems pose challenges but also offer opportunities for discovery.",
            "signal expertise": "The speaker is sharing his understanding of the challenges and opportunities in complex cell systems, which relates to his expertise."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: So how do we find that sweet spot? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on how to find the 'sweet spot' mentioned in the previous discussion."
        }
    },
    {
        "utterance": "Arnold Hayer: Pushing I don't know. That's the question, right? ",
        "annotations": {
            "identify gap": "The speaker acknowledges a lack of knowledge or uncertainty about how to find the 'sweet spot', indicated by 'I don't know'.",
            "express humor": "The speaker's tone could be interpreted as slightly humorous or resigned with 'That's the question, right?'"
        }
    },
    {
        "utterance": "Arnold Hayer: Well, I think finding the ideal find finding a transparent uh model and uh finding good reporters and uh and uh a good a gentle a gentle way of of imaging the system. ",
        "annotations": {
            "develop idea": "Arnold Hayer is expanding on existing ideas by suggesting specific actions for finding a suitable model and imaging technique.",
            "offer feedback": "Arnold Hayer is providing suggestions for moving forward with the research."
        }
    },
    {
        "utterance": "Brian Pogue: Um, I think Arnold was heading down the route of um. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mark Selimyer: Finding good three uh good three dimensional system because we're pretty good at two dimensional right now, but like finding a good three dimensional system to look at cell movements is maybe a good interim step before getting to to animals. ",
        "annotations": {
            "propose new idea": "The speaker introduces a new approach by suggesting to find a good three-dimensional system.",
            "develop idea": "The speaker builds upon the existing idea of improving their current methods.",
            "identify gap": "The speaker explicitly mentions a gap in their current capabilities, specifically in studying three-dimensional systems."
        }
    },
    {
        "utterance": "Ping Wang: We talk talk a lot about the single cell imaging. Um, probably we should add that. Yeah, I mean. ",
        "annotations": {
            "propose new idea": "The speaker suggests adding single-cell imaging to their discussion or list, introducing a new idea for consideration.",
            "supportive response": "The utterance also expresses agreement with the importance of single-cell imaging, showing a supportive stance towards the topic."
        }
    },
    {
        "utterance": "Mark Selimyer: Ping doesn't think it's a good idea. ",
        "annotations": {
            "acknowledge contribution": "Mark Selimyer is referencing Ping Wang's input, recognizing her contribution to the discussion.",
            "critical response": "Mark Selimyer is providing a negative evaluation of an idea based on Ping's input."
        }
    },
    {
        "utterance": "Mark Selimyer: Ha ha ha. ",
        "annotations": {
            "express humor": "Mark Selimyer is making a joke."
        }
    },
    {
        "utterance": "Ping Wang: No, no, no. I I think it's a brilliant idea. I like the like a push the push the technology. I mean, uh hard I mean to to help help the people like me for the application. I just I just want to have like a more justification. What are you going to do for the single cell imaging? I really like this. ",
        "annotations": {
            "supportive response": "The speaker expresses agreement and a positive evaluation of the idea proposed.",
            "ask question": "The speaker requests more information or justification about the proposal, specifically for single cell imaging."
        }
    },
    {
        "utterance": "Mark Selimyer: No, I I I tend to agree with you. So I was throwing you under the bus there. But you know, it's generally populations of cells that we care most about, especially like therapeutically or you know, I I actually actually let me take it back. Let me take it back. So it could be that single cell is super important for something like development, you know, developmental biology, sort of what Crystal studies. ",
        "annotations": {
            "develop idea": "Mark expands on the idea of cell populations versus single-cell imaging.",
            "supportive response": "Mark agrees with and supports Ping's idea.",
            "express humor": "Mark uses humor when saying 'So I was throwing you under the bus there.'"
        }
    },
    {
        "utterance": "Mark Selimyer: But then maybe on like the therapeutic side it's more like, well, you put in 50 million car T cells and you just want to know where they go and you need to have some. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by providing a specific example related to the therapeutic side of the topic, building upon previous discussions."
        }
    },
    {
        "utterance": "Ping Wang: I can come up one application I can come up with I'm not sure if that's that's feasible. Like for the detecting the what does the static cells. You can generate something like um pad reporter genes and detect the single cells uh detached from the primary lesion and that's a good application for the for the like early detection. That's very critical for the cancer. ",
        "annotations": {
            "propose new idea": "The speaker introduces a new application for detecting static cells using pad reporter genes.",
            "develop idea": "The speaker elaborates on the potential use of pad reporter genes for detecting single cells detached from the primary lesion for early cancer detection.",
            "ask question": "The speaker asks about the feasibility of their proposed idea."
        }
    },
    {
        "utterance": "Mark Selimyer: So would it be safe to say that single cell is. ",
        "annotations": {
            "ask question": "The speaker is seeking confirmation or clarification on the accuracy of making a statement about 'single cell', indicating a request for information or validation from other team members."
        }
    },
    {
        "utterance": "Mark Selimyer: Helpful to determine, you know, underlying biology and that population movements may be more important for understanding therapies. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by highlighting the importance of single-cell imaging for understanding underlying biology and population movements for therapies.",
            "supportive response": "The utterance provides a perspective that aligns with and supports previous discussions."
        }
    },
    {
        "utterance": "Mark Selimyer: Maybe. ",
        "annotations": {
            "supportive response": "The utterance 'Maybe.' serves as a weak acknowledgment or agreement, indicating a supportive stance without adding substantial content."
        }
    },
    {
        "utterance": "Ping Wang: Yeah. ",
        "annotations": {
            "supportive response": "The utterance expresses agreement with a previous statement, validating the contribution without adding new content."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: All right. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Crystal Rogers- UC Davis: mechanism in vivo. ",
        "annotations": {
            "None": "No relevant code perfectly applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Um yeah, we also talked about I liked the conversation about iron oxide particles. I personally don't um have any experience with that, but I thought that was a really nice contrast agent as well as the micro bubbles for ultrasound. ",
        "annotations": {
            "summarize conversation": "The speaker references and summarizes previous conversations about iron oxide particles and microbubbles for ultrasound.",
            "develop idea": "The speaker expands on previous ideas by discussing the potential of iron oxide particles and microbubbles as contrast agents."
        }
    },
    {
        "utterance": "Brad Smith: Well that seemed to be part of the the two paradigms here. One was that you would have to label exogenous cells and then you introduce them and then you track them and so then the question becomes what's the best label and you've just talked of a couple and then the that that paradigm changes to one where you're now presumably adding a contrast agent that's going to go and find a certain cell population and then stick to it or maybe longitudinally lay, you know, keep redosing all the time. There seem to be two general strategies. Each have their own particular technical challenges. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous discussions by describing two paradigms for approaching a problem, elaborating on the processes involved.",
            "summarize conversation": "The speaker summarizes the conversation by highlighting two general strategies and their technical challenges."
        }
    },
    {
        "utterance": "Brian Pogue: And yeah, Mark, you you were talking about biologically altering cells so that you could image them. And I presume that is ex vivo and then introduced in vivo. You know. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it primarily involves Brian Pogue clarifying his understanding of a previous discussion, which doesn't neatly fit into the provided categories."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Um okay, is this uh ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ping Wang: I I have one um one point I'm not sure. I mean, if we should add I I think probably theranostics as I said um label the cells using the reporter gene to say the cells. That's one one um one thing um um I mean, probably we should also uh pay some attention on the uh theranostic like protect the cells or control the cells function after you put the cells in for the transplantation. Um I don't know. I have idea um because of this uh COVID-19 uh vaccine, uh we had we had work on the SRI uh SRA um conjugation to the nanoparticles to uh silence the harmful genes for the cells related to apoptosis or related to the new rejection. Um I was fascinated uh to read the papers and I I also I got the vaccine uh to to know uh the the nanoparticle can deliver the RNA to to your immune cells. So um I mean if we can um work on some like imaging to see the um how this RNA uh works because because um because um before this uh COVID-19 before this uh vaccine uh it's hard for me to understand how you can deliver um like RNA to the cells and the cells going to translate to the protein and this protein can can be recognized by um immune cells. ",
        "annotations": {
            "propose new idea": "Ping Wang introduces the idea of using theranostics to label cells and potentially control their function after transplantation.",
            "develop idea": "He elaborates on this idea by referencing his experience with COVID-19 vaccines and the use of nanoparticles to deliver RNA to immune cells, suggesting potential for imaging applications."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Where should I put that, Ping? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification from Ping on where to put something, indicating a question being asked."
        }
    },
    {
        "utterance": "Ping Wang: I would suggest ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: So we're like fighting for space here, so what would be the best place to put it? ",
        "annotations": {
            "ask question": "The speaker is asking for suggestions on where to place something.",
            "process management": "The speaker is managing the organization of content considering space constraints."
        }
    },
    {
        "utterance": "Ping Wang: I would suggest have like another one like theranostics imaging. ",
        "annotations": {
            "propose new idea": "Ping Wang is suggesting adding a new topic area related to 'theranostics imaging'.",
            "process management": "Ping Wang's suggestion contributes to organizing their discussion by proposing a new category."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Theranostics. ",
        "annotations": {
            "acknowledge contribution": "The speaker is acknowledging Ping Wang's previous suggestion by noting 'Theranostics.'"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Um ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: How do you spell that? I don't I I haven't heard that word before. ",
        "annotations": {
            "ask question": "The speaker is requesting information about the spelling of a word.",
            "identify gap": "The speaker is expressing his lack of familiarity with a term."
        }
    },
    {
        "utterance": "Ping Wang: Therapy. Therapy plus diagnose and then ",
        "annotations": {
            "develop idea": "The speaker is attempting to break down the concept of theranostics into its basic components, thereby expanding on an existing idea.",
            "clarify goal": "The utterance helps in clarifying the goal or concept of theranostics by defining it as therapy plus diagnosis."
        }
    },
    {
        "utterance": "Ping Wang: Theranostics. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ping Wang: I can uh I know I have ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "The utterance is a brief acknowledgment without adding new content or specifying actions."
        }
    },
    {
        "utterance": "Brad Smith: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "supportive response": "The utterance 'Okay.' by Brad Smith expresses agreement or acknowledgment of a previous statement, fitting the definition of a supportive response."
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "The utterance does not explicitly add new information, develop an idea, ask a question, or clearly acknowledge a previous contribution in a substantial way."
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is a minimal acknowledgment."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "Supportive response": "The utterance 'Okay.' by Brad Smith serves as a minimal acknowledgment or agreement with previous statements, indicating a supportive response without adding new content."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "The utterance 'Okay.' does not add new information and is too minimal to be considered a substantial acknowledgment of a contribution."
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "Acknowledge contribution": "The speaker is acknowledging a previous statement or contribution without adding new content."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "The utterance 'Okay.' does not explicitly fit into any of the provided categories as it is a minimal response used for acknowledgment."
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "The utterance is a simple acknowledgment without adding significant content or context to the conversation."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "The utterance 'Okay.' is too brief and does not explicitly exhibit any of the defined codes; it seems to be an acknowledgment or agreement without adding new content."
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "supportive response": "The utterance 'Okay.' expresses agreement or validation of a previous statement without adding new content."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "supportive response": "The utterance 'Okay.' is a minimal response that expresses agreement or validation, fitting the definition of a supportive response."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): Not too much. There's, yeah, there are things like FDG that measures your metabolism, but you're looking at the body's own metabolism, um, and up regulated in immune cells. So there's a group down at Johns Hopkins, um, Sanjay Jane's group has been working on this and they've got some, um, labeled sorbitol for pet imaging, which is kind of cool because we don't take, we don't use sorbitol as a carbon source, but bugs do. Um, we're using an antibiotic, uh, trimethoprim to image bacteria themselves. Other people are using D amino acids. So there's a whole, you know, like chemistry world that's out there trying to develop probes specific for your question, um, you know, Brad about how to image pathology, um, using these probe development approaches. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea of imaging techniques and probe development, building upon existing knowledge.",
            "signal expertise": "The speaker is showing expertise in the field by mentioning specific techniques and research groups.",
            "supportive response": "The tone is informative and positive, supporting the discussion."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: There's a lot of focus on immune probes, but it seems like metabolic probes are a whole lot easier because they wind up, the concentrations wind up being orders of magnitude higher. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by comparing immune and metabolic probes and providing a rationale for why metabolic probes seem easier.",
            "supportive response": "The speaker provides a form of positive evaluation for metabolic probes, suggesting they are easier to work with."
        }
    },
    {
        "utterance": "Brad Smith, Notre Dame: The problem with metabolic probes is that the cells have to be metabolically active. So you know, in the bacteria, once you get biofilms and the things calm down, then then really they're not taking up much stuff and so they get harder metabolic probes struggle that way then. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on the challenges of using metabolic probes by explaining the condition under which they struggle to work.",
            "identify gap": "The speaker is highlighting a limitation or a challenge (gap) in using metabolic probes, which is that they only work if the cells are metabolically active."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: I think there's some cool research too. ",
        "annotations": {
            "Supportive Response": "Brian Pogue is expressing a positive sentiment towards research, indicating agreement or validation of previous discussions."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): Brian from, you know, Anna Woo's group out at City of Hope and and you probably know her and looking at immune cells, cell surface markers, right? So how do you track CD8 T cells and them wandering around and getting into tumors or not with immunotherapies and things like that. ",
        "annotations": {
            "ask question": "The speaker ends with a question about tracking CD8 T cells, seeking information or discussion.",
            "signal expertise": "The speaker demonstrates knowledge of specific research areas and mentions researchers, signaling their expertise or familiarity with the topic."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Yeah, the challenge I always talk about is is immunology exists at the nanomolar level really and and and metabolism exists at the micromolar level and it's it's a whole lot easier to image micromolars than it is to image nanomolars. ",
        "annotations": {
            "identify gap": "The speaker is highlighting a gap in the ability to easily image at the nanomolar level compared to the micromolar level.",
            "critical response": "The speaker is discussing a challenge, which implies a negative aspect of the current state of imaging technology."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): I think they're going after, you know, cell specific markers that are on the surface using things like immuno pet probes where you've got an antibody that's specific for that. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by discussing the use of immuno PET probes for targeting cell-specific markers.",
            "signal expertise": "The speaker is explicitly stating his knowledge in the field, specifically regarding immuno PET probes and their application."
        }
    }
]